These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 27077227)
1. Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53. Liu WT; Jing YY; Yu GF; Chen H; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX Cell Cycle; 2016; 15(7):886-94. PubMed ID: 27077227 [TBL] [Abstract][Full Text] [Related]
2. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1. Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209 [TBL] [Abstract][Full Text] [Related]
3. Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma. Yu G; Jing Y; Kou X; Ye F; Gao L; Fan Q; Yang Y; Zhao Q; Li R; Wu M; Wei L PLoS One; 2013; 8(9):e73312. PubMed ID: 24023859 [TBL] [Abstract][Full Text] [Related]
4. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway. Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668 [TBL] [Abstract][Full Text] [Related]
5. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway. Zhang R; Gao X; Zuo J; Hu B; Yang J; Zhao J; Chen J Cancer Sci; 2020 Feb; 111(2):406-417. PubMed ID: 31785057 [TBL] [Abstract][Full Text] [Related]
6. LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway. Bu WJ; Fang Z; Li WL; Wang X; Dong MJ; Tao QY; Zhang L; Xu YQ Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10452-10461. PubMed ID: 33155201 [TBL] [Abstract][Full Text] [Related]
7. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. Tan S; Li R; Ding K; Lobie PE; Zhu T FEBS Lett; 2011 Jul; 585(14):2229-34. PubMed ID: 21658389 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic stellate cells increase pancreatic cancer cells invasion through the hepatocyte growth factor /c-Met/survivin regulated by P53/P21. Yang XP; Liu SL; Xu JF; Cao SG; Li Y; Zhou YB Exp Cell Res; 2017 Aug; 357(1):79-87. PubMed ID: 28461158 [TBL] [Abstract][Full Text] [Related]
9. Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis. Rhee H; Kim HY; Choi JH; Woo HG; Yoo JE; Nahm JH; Choi JS; Park YN Cancer Res; 2018 Apr; 78(7):1619-1631. PubMed ID: 29363547 [TBL] [Abstract][Full Text] [Related]
10. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target. Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Lee HJ; Eun JY; Kim HG; Yoon SS; Lee DS; Kim JH; Kim JR Clin Exp Metastasis; 2008; 25(1):89-96. PubMed ID: 17992475 [TBL] [Abstract][Full Text] [Related]
11. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849 [TBL] [Abstract][Full Text] [Related]
12. C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway. Zhao M; Wang Y; Liu Y; Zhang W; Liu Y; Yang X; Cao Y; Wang S Cancer Biol Ther; 2019; 20(12):1430-1442. PubMed ID: 31441380 [TBL] [Abstract][Full Text] [Related]
13. Diospyros kaki leaves inhibit HGF/Met signaling-mediated EMT and stemness features in hepatocellular carcinoma. Ko H; Huh G; Jung SH; Kwon H; Jeon Y; Park YN; Kim YJ Food Chem Toxicol; 2020 Aug; 142():111475. PubMed ID: 32522589 [TBL] [Abstract][Full Text] [Related]
14. SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma. Zhang W; Sun H; Shi X; Wang H; Cui C; Xiao F; Wu C; Guo X; Wang L Tumour Biol; 2016 Jun; 37(6):7741-8. PubMed ID: 26695141 [TBL] [Abstract][Full Text] [Related]
15. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression. Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849 [TBL] [Abstract][Full Text] [Related]
16. Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression. Fu R; Jiang S; Li J; Chen H; Zhang X Med Oncol; 2020 Mar; 37(4):24. PubMed ID: 32166604 [TBL] [Abstract][Full Text] [Related]
17. MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met. Korhan P; Erdal E; Atabey N Biochem Biophys Res Commun; 2014 Aug; 450(4):1304-12. PubMed ID: 25058462 [TBL] [Abstract][Full Text] [Related]
18. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Jiang Y; Xu W; Lu J; He F; Yang X Biochem Biophys Res Commun; 2001 Sep; 286(5):1123-30. PubMed ID: 11527416 [TBL] [Abstract][Full Text] [Related]
19. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion. Huang FI; Chen YL; Chang CN; Yuan RH; Jeng YM Carcinogenesis; 2012 Jun; 33(6):1142-8. PubMed ID: 22436613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]